A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention

https://doi.org/10.1016/j.ijcard.2016.12.095Get rights and content

Abstract

Background

A few studies developed simple risk model for predicting CIN with poor prognosis after emergent PCI. The study aimed to develop and validate a novel tool for predicting the risk of contrast-induced nephropathy (CIN) in patients undergoing emergent percutaneous coronary intervention (PCI).

Methods

692 consecutive patients undergoing emergent PCI between January 2010 and December 2013 were randomly (2:1) assigned to a development dataset (n = 461) and a validation dataset (n = 231). Multivariate logistic regression was applied to identify independent predictors of CIN, and established CIN predicting model, whose prognostic accuracy was assessed using the c-statistic for discrimination and the Hosmere Lemeshow test for calibration.

Results

The overall incidence of CIN was 55(7.9%). A total of 11 variables were analyzed, including age > 75 years old, baseline serum creatinine (SCr) > 1.5 mg/dl, hypotension and the use of intra-aortic balloon pump(IABP), which were identified to enter risk score model (Chen). The incidence of CIN was 32(6.9%) in the development dataset (in low risk (score = 0), 1.0%, moderate risk (score:1–2), 13.4%, high risk (score  3), 90.0%). Compared to the classical Mehran's and ACEF CIN risk score models, the risk score (Chen) across the subgroup of the study population exhibited similar discrimination and predictive ability on CIN (c-statistic:0.828, 0.776, 0.853, respectively), in-hospital mortality, 2, 3-years mortality (c-statistic:0.738.0.750, 0.845, respectively) in the validation population.

Conclusions

Our data showed that this simple risk model exhibited good discrimination and predictive ability on CIN, similar to Mehran's and ACEF score, and even on long-term mortality after emergent PCI.

Introduction

Contrast-induced nephropathy (CIN) develops as a complication after coronary diagnostic and interventional procedures, and is associated with increased mortality, longer hospitalization stays, increased health care costs, and higher risk of adverse clinical outcomes, especially among patients undergoing emergent or primary percutaneous coronary intervention (PCI) [1], [2], [3], [4], [5]. The risk of CIN after emergent PCI is significantly higher than after elective PCI [6], [7], [8].

Current clinical guidelines suggest that patients should be assessed for the risk of CIN after PCI [9], [10] with CIN predictive model included patient-related risk factors (advanced age, renal insufficiency, hypotension, intra-aortic balloon pump, diabetes mellitus) or procedure-related risk factors (large contrast volume, insufficient hydration and high osmolality agents) [11], [12], [13]. The hemodynamic unstable markers, including reduced ejection fraction, cardiogenic shock, hypotension were reported as the most import risk factors of CIN after emergent PCI [14], [15], [16], [17].

Although the combination of above risk factors is common, a cumulative risk score model for prediction for CIN and prognosis among patients undergoing emergent PCI is limited in clinical practice. The most commonly used Mehran's risk score model comprised 8 variables, which was established and validated in patients without acute myocardial infarction (AMI) [11]. And majority of other models use variables that are not known at the time of an emergent PCI [12], [13]. There is a need to develop a simple and rapid risk prediction tool for patient with ST-elevation-myocardial infarction (STEMI) or non-ST-elevation acute coronary syndromes (NSTE-ACS), who are at higher risk of undergoing emergent PCI. Therefore, in this prospective study, the purpose was to develop a simple risk score model that could be rapidly applied to evaluate the risk of CIN following emergent PCI.

Section snippets

Study population

Data for this study were obtained from a prospective observational study that included all consecutive patients who underwent coronary angiography or PCI between January 2010 and December 2013 in Guangdong general hospital. Patients [14] were included if they were diagnosed with STEMI and presented quite high risk in those with NSTE-ACS (i.e., those with refractory angina, hemodynamic instability) in the analysis. The exclusion criteria were pregnancy, lactation, intravascular administration of

Baseline characteristics

The cumulative incidence of CIN was 55 (7.9%) in the whole study population (n = 692), of which, 32(6.9%) in the development dataset. The comparison of the baseline clinical and procedural characteristics of subgroups defined by CIN0.5 were listed in Table 1. Overall (Table 1-A), the mean age was 62.2 years (SD 12.4 years), and there were 132 (16.8%) females. The mean baseline serum creatinine level was 1 mg/dl (SD 0.47 mg/dl), whereas 80 (11.6%) of patients presented creatinine levels > 1.5 mg/dl. 73

Discussion

In the present study, we established and validated a simple, novel CIN risk score including four risk factors: age > 75 years, SCr > 1.5 mg/dl, hypotension and the use of IABP for developing CIN risk stratification tool among patients undergoing emergent PCI. Our simple, novel risk score (Chen) model demonstrated good discrimination and predictive ability on CIN, and even for long-term outcomes after emergent PCI, which maybe a good alternative to other models.

Mehran's risk score model, which is

Conclusion

There is a need for a simple and robust risk tool for prediction of CIN and prognosis in patients undergoing emergent PCI. Our simple, novel risk score (Chen) model demonstrated good discrimination and predictive ability on CIN with similar predictive value for long-term outcomes after emergent PCI, which maybe a good alternative to other models. However, the accuracy of our Chen model needs to be validated in further large scan of cohorts.

The following are the supplementary data related to

Funding sources

This work was supported by the Guangdong Provincial Cardiovascular Clinical Medicine Research Fund (grant number 2009X41 to Y.L. and N.T.); Science and Technology Planning Project of Guangdong Province (PRECOMIN study by Y.L. in 2011 and study grant number 2008A030201002 to JY.C.); and the Guangdong Cardiovascular Institute, the Youth project of Fujian provincial health and Family Planning Commission (grant number 2015-1-9).

Disclosures

None.

References (48)

  • D. Tziakas et al.

    Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention

    Am. J. Cardiol.

    (2014)
  • H.S. Gurm et al.

    Novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention

    J. Am. Coll. Cardiol.

    (2013)
  • A. Bouzas-Mosquera et al.

    Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis

    Rev. Esp. Cardiol.

    (2007)
  • G. Davidavicius et al.

    Incidence of overall bleeding in patients treated with intra-aortic balloon pump during percutaneous coronary intervention: 12-year Milan experience

    JACC Cardiovasc. Interv.

    (2012)
  • A. Jeremias et al.

    Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction

    Am. J. Cardiol.

    (2010)
  • Y.H. Liu et al.

    Comparison of different risk scores for predicting contrast induced nephropathy and outcomes after primary percutaneous coronary intervention in patients with ST elevation myocardial infarction

    Am. J. Cardiol.

    (2016)
  • D. Ozturk et al.

    Utility of the logistic clinical syntax score in the prediction of contrast-induced nephropathy after primary percutaneous coronary intervention

    Can. J. Cardiol.

    (2016)
  • A. Jurado-Román et al.

    Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention

    Am. J. Cardiol.

    (2015)
  • J.L. Zhao et al.

    Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty

    Int. J. Cardiol.

    (2008)
  • A. Bouzas-Mosquera et al.

    Statin therapy and contrast-induced nephropathy after primary angioplasty

    Int. J. Cardiol.

    (2009)
  • E. Seeliger et al.

    Contrast-induced kidney injury: mechanisms, risk factors, and prevention

    Eur. Heart J.

    (2012)
  • Y. Liu et al.

    Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy

    Circ. Cardiovasc. Interv.

    (2015)
  • E. Aslanger et al.

    Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty

    Coron. Artery Dis.

    (2012)
  • J. Wi et al.

    Prediction of contrast-induced nephropathy with persistent renal dysfunction and adverse long-term outcomes in patients with acute myocardial infarction using the Mehran risk score

    Clin. Cardiol.

    (2013)
  • Cited by (37)

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text